Mahesh Karande

Mahesh Karande

Director/Board Member at
KSQ Therapeutics, Inc.
53 year
Health Technology
Consumer Services
Retail Trade

Profile

Mahesh Karande is currently a Director at Ashvattha Therapeutics Inc since 2023 and a Director at KSQ Therapeutics, Inc. since 2022.
Previously, he held the position of President & Chief Executive Officer at Zikani Therapeutics, Inc. from 2018 to 2019, President, Chief Executive Officer & Director at Omega Therapeutics, Inc. from 2019 to 2024, Vice President & Head-US Oncology at Novartis, Inc. from 2010 to 2017, President at Novartis SA from 2010 to 2017, and President at Novartis Pharma SAE from 2010 to 2017.
Mr. Karande has a graduate degree from Georgia Institute of Technology, an undergraduate degree from the University of Mumbai, and an MBA from The Wharton School of the University of Pennsylvania.

Mahesh Karande active positions

CompaniesPositionStart
Director/Board Member 08/12/2022
Director/Board Member 31/05/2023

Former positions of Mahesh Karande

CompaniesPositionEnd
OMEA THER Chief Executive Officer 14/11/2024
Chief Executive Officer 01/03/2019
President 01/04/2017
President 01/04/2017
Corporate Officer/Principal 01/04/2017
See the detail of Mahesh Karande's experience

Training of Mahesh Karande

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

3

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Retail Trade

Consumer Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Mahesh Karande